Form 8-K - Current report:
SEC Accession No. 0001829126-24-008411
Filing Date
2024-12-19
Accepted
2024-12-19 16:05:26
Documents
16
Period of Report
2024-12-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zeoscientifix_8k.htm   iXBRL 8-K 27941
2 EXHIBIT 3.1 zeoscientifix_ex3-1.htm EX-3.1 8921
3 GRAPHIC ex3-1_001.jpg GRAPHIC 1038123
4 GRAPHIC ex3-1_002.jpg GRAPHIC 513302
  Complete submission text file 0001829126-24-008411.txt   2296695

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ocel-20241217.xsd EX-101.SCH 2991
6 XBRL LABEL FILE ocel-20241217_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ocel-20241217_pre.xml EX-101.PRE 22343
18 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifix_8k_htm.xml XML 3463
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 241563312
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)